Lifeway Foods, Inc. (NASDAQ: LWAY) is a Consumer Defensive company in the Packaged Foods industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 24.64 | EPS (ttm) | 0.97 | Insider Own | - | Shs Outstand | 15.28M | Perf Week | -2.89% |
| Market Cap | 361.05M | Forward P/E | 18.70 | EPS next Y | 1.28 | Insider Trans | -29.51% | Shs Float | 5.83M | Perf Month | -4.55% |
| Enterprise Value | 380.24M | PEG | 0.62 | EPS next Q | 0.06 | Inst Own | - | Short Float | 2.79% | Perf Quarter | -6.02% |
| Income | 16.00M | P/S | 1.59 | EPS this Y | -46.42% | Inst Trans | - | Short Ratio | 2.37 | Perf Half Y | 34.04% |
| Sales | 229.00M | P/B | 4.30 | EPS next Y | 145.86% | ROA | 8.21% | Short Interest | 426.54K | Perf YTD | -1.36% |
| Book/sh | 5.56 | P/C | 52.17 | EPS next 5Y | 39.53% | ROE | 12.66% | 52W High | 32.71 -26.93% | Perf Year | -29.33% |
| Cash/sh | 0.46 | P/FCF | - | EPS past 3/5Y | 147.36% 33.49% | ROIC | 10.05% | 52W Low | 17.31 38.07% | Perf 3Y | 99.17% |
| Dividend Est. | - | EV/EBITDA | 15.21 | Sales past 3/5Y | 14.29% 15.76% | Gross Margin | 26.01% | Volatility | 3.69% 3.27% | Perf 5Y | 361.39% |
| Dividend TTM | - | EV/Sales | 1.66 | EPS Y/Y TTM | 64.41% | Oper. Margin | 6.49% | ATR (14) | 0.99 | Perf 10Y | 82.16% |
| Dividend Ex-Date | May 29, 2013 | Quick Ratio | 1.47 | Sales Y/Y TTM | 22.46% | Profit Margin | 4.48% | RSI (14) | 31.14 | Recom | 2.29 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.09 | EPS Q/Q | -96.43% | SMA20 | -5.65% | Beta | 0.46 | Target Price | 32.00 |
| Payout | 0.00% | Debt/Eq | 0.00 | Sales Q/Q | 24.07% | SMA50 | -14.38% | Rel Volume | 4.31 | Prev Close | 23.79 |
| Employees | 293 | LT Debt/Eq | 0.02 | Earnings | Nov 12 | SMA200 | -3.45% | Avg Volume | 185.03K | Price | 23.90 |
| IPO Date | Dec 29, 1988 | Option/Short | No / Yes | EPS/Sales Surpr. | -96.23% 8.95% | Net Debt/EBITDA | 0.78 | Volume | 797,920 | Change | 0.46% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-20-26 | Initiated | BTIG | Buy | $32 |
| Aug-14-26 | Upgrade | Freedom Broker | Hold → Buy | |
| May-15-26 | Downgrade | Freedom Broker | Buy → Hold | |
| Jan-14-26 | Reiterated | Morgan Stanley | $35 | |
| Sep-24-24 | Downgrade | Noble Capital Markets | Outperform → Market Perform | |
| Mar-27-24 | Downgrade | Noble Capital Markets | Outperform → Market Perform | |
| Feb-26-24 | Upgrade | Noble Capital Markets | Market Perform → Outperform | |
| Nov-27-23 | Downgrade | Noble Capital Markets | Outperform → Market Perform | |
| Nov-14-23 | Upgrade | Noble Capital Markets | Market Perform → Outperform | |
| Sep-25-23 | Downgrade | Noble Capital Markets | Outperform → Market Perform |
Lifeway Foods, Inc. manufactures and distributes a variety of probiotic-rich goods, serving both the United States and international markets. Its principal offering is drinkable kefir, a fermented dairy item available in numerous forms, including organic and conventional options, various volumes, flavors, and formulations such as reduced-fat, fat-free, whole milk, high-protein, and BioKefir. Additionally, the company supplies European-style soft cheeses, cream, and other dairy selections. Their product portfolio also features ProBugs, a dedicated kefir line for children; single-serving cupped kefirs; Icelandic Skyr, which includes strained kefir and yogurt products; and frozen kefir in both soft-serve and pre-packaged pint formats. These products are sold under their proprietary Lifeway and Fresh Made brand names, and also as private label merchandise for other customers. Sales are primarily conducted via their internal sales personnel, alongside the use of brokers and third-party distributors. The company was founded in 1986 and maintains its headquarters in Morton Grove, Illinois.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 229 | 212 | 187 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 165 | 154 | 138 | — | — | — | — | — | — | |
| Gross Profit | 64 | 58 | 49 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 42 | 41 | 34 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 3 | 1 | 1 | — | — | — | — | — | — | |
| Operating Income | 21 | 16 | 14 | — | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 4 | 0 | — | — | — | — | — | — | |
| Net Income Before Taxes | 21 | 20 | 14 | — | — | — | — | — | — | |
| Income Taxes | 7 | 6 | 5 | — | — | — | — | — | — | |
| Consolidated Net Income | 16 | 14 | 9 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 16 | 14 | 9 | — | — | — | — | — | — | |
| Net Income | 16 | 14 | 9 | — | — | — | — | — | — | |
| EPS (Recurring) | 0.99 | 0.91 | 0.61 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.99 | 0.91 | 0.61 | — | — | — | — | — | — | |
| EPS (Diluted) | 0.97 | 0.89 | 0.59 | — | — | — | — | — | — | |
| EBITDA | 25 | 24 | 17 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 24.64 | 27.22 | 42.03 | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.57 | 1.71 | 1.99 | — | — | — | — | — | — | |
| Gross Margin | 27.95 | 27.36 | 26.20 | — | — | — | — | — | — | |
| Operating Margin | 9.17 | 7.55 | 7.49 | — | — | — | — | — | — | |
| Net Margin | 6.99 | 6.60 | 4.81 | — | — | — | — | — | — | |
| Shares Outstanding | 15 | 15 | 15 | — | — | — | — | — | — | |
| Market Capitalization | 359 | 363 | 372 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| McWhorter Dorri | Director | Aug 31 '26 | Option Exercise | 0.00 | 1,550 | 0 | 28,842 | Sep 02 |
| SCHER JASON SCOTT | Director | Aug 31 '26 | Option Exercise | 0.00 | 1,550 | 0 | 84,608 | Sep 02 |
| Dalto Juan Carlos | Director | Aug 31 '26 | Option Exercise | 0.00 | 1,550 | 0 | 10,771 | Sep 02 |
| SMOLYANSKY JULIE | CEO, President and Secretary | Aug 19 '26 | Buy | 25.26 | 2,000 | 50,520 | 2,214,095 | Aug 19 |
| Divisadero Street Capital Management, LP | 10% Owner | Aug 17 '26 | Buy | 24.78 | 35,952 | 890,923 | 2,348,108 | Aug 17 |
| Divisadero Street Capital Management, LP | 10% Owner | Aug 14 '26 | Buy | 24.69 | 15,000 | 370,352 | 2,312,156 | Aug 17 |
| Divisadero Street Capital Management, LP | 10% Owner | Aug 13 '26 | Buy | 24.87 | 195,616 | 4,865,537 | 2,297,156 | Aug 17 |
| SMOLYANSKY EDWARD | 10% Owner | Aug 14 '26 | Sale | 25.45 | 75,000 | 1,908,686 | 894,793 | Aug 14 |
| SMOLYANSKY EDWARD | 10% Owner | Aug 12 '26 | Sale | 28.74 | 35,000 | 1,005,900 | 969,793 | Aug 14 |
| SMOLYANSKY LUDMILA | other: Member of 10% owner group | Jul 22 '26 | Sale | 30.11 | 100,000 | 3,011,400 | 507,207 | Jul 23 |
| SMOLYANSKY EDWARD | 10% Owner | Jul 15 '26 | Sale | 32.02 | 66,916 | 2,142,756 | 1,004,793 | Jul 16 |
| SMOLYANSKY EDWARD | 10% Owner | Jul 07 '26 | Sale | 29.41 | 39,098 | 1,149,872 | 1,071,709 | Jul 09 |
| SMOLYANSKY EDWARD | 10% Owner | Jul 06 '26 | Sale | 29.79 | 7,984 | 237,843 | 1,110,807 | Jul 09 |
| McWhorter Dorri | Director | Jul 01 '26 | Option Exercise | 0.00 | 1,356 | 0 | 27,292 | Jul 02 |
| SCHER JASON SCOTT | Director | Jul 01 '26 | Option Exercise | 0.00 | 1,356 | 0 | 83,058 | Jul 02 |